Drug Profile
TS 111
Alternative Names: TS-111Latest Information Update: 26 May 2016
Price :
$50
*
At a glance
- Originator Taisho Pharmaceutical
- Class Antidepressants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Depressive disorders
Most Recent Events
- 10 May 2013 Phase-I clinical trials in Depressive disorders (unspecified route)